AB 703: California Pediatric Cancer Research Voluntary Tax Contribution Fund.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2025-07-28
Current Status:
Passed
(2025-07-28: Chaptered by Secretary of State - Chapter 63, Statutes of 2025.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
Existing law allows an individual taxpayer to contribute amounts in excess of their personal income tax liability for the support of specified funds and accounts, including, among others, to the California Cancer Research Voluntary Tax Contribution Fund.
This bill would allow an individual to designate on their tax return that a specified amount in excess of their tax liability be transferred to the continuously appropriated California Pediatric Cancer Research Voluntary Tax Contribution Fund, which would be created by this bill. The bill would require the Franchise Tax Board to revise the tax return form to include a space for the designation of contributions to the fund when another voluntary designation is removed from the form or there is space, whichever occurs first. By establishing a new continuously appropriated fund, this bill would make an appropriation. The bill would require that the above provisions remain operative only until January 1 of the 7th calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, except as specified.
Existing law allows an individual taxpayer to contribute amounts in excess of their personal income tax liability for the support of specified funds and accounts, including, among others, to the California Cancer Research Voluntary Tax Contribution Fund.
This bill would allow an individual to designate on their tax return that a specified amount in excess of their tax liability be transferred to the continuously appropriated California Pediatric Cancer Research Voluntary Tax Contribution Fund, which would be created by this bill. The bill would require the Franchise Tax Board to revise the tax return form to include a space for the designation of contributions to the fund when another voluntary designation is removed from the form or there is space, whichever occurs first. By establishing a new continuously appropriated fund, this bill would make an appropriation. The bill would require that the above provisions remain operative only until January 1 of the 7th calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, except as specified.
Existing law allows an individual taxpayer to contribute amounts in excess of their personal income tax liability for the support of specified funds and accounts, including, among others, to the California Cancer Research Voluntary Tax Contribution Fund.
This bill, until January 1, 2033, except as otherwise specified, bill would allow an individual to designate on their tax return that a specified amount in excess of their tax liability be transferred to the continuously appropriated California Pediatric Cancer Research Voluntary Tax Contribution Fund, which would be created by this bill. The bill would require the Franchise Tax Board to revise the tax return form to include a space for the designation of contributions to the fund when another voluntary designation is removed from the form or there is space, whichever occurs first. By establishing a new continuously appropriated fund, this bill would make an appropriation. The bill would require that the above provisions remain operative only until January 1 of the 7th calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, except as specified.
Existing law allows an individual taxpayer to contribute amounts in excess of their personal income tax liability for the support of specified funds and accounts, including, among others, to the California Cancer Research Voluntary Tax Contribution Fund.
This bill, until January 1, 2033, except as otherwise specified, would allow an individual to designate on their tax return that a specified amount in excess of their tax liability be transferred to the continuously appropriated California Pediatric Cancer Research Voluntary Tax Contribution Fund, which would be created by this bill. The bill would require the Franchise Tax Board to revise the tax return form to include a space for the designation of contributions to the fund when another voluntary designation is removed from the form or there is space, whichever occurs first. By establishing a new continuously appropriated fund, this bill would make an appropriation.
The Corporation Tax Law imposes taxes upon a corporation doing business in this state, according to, or measured by, net income, as specified. The Corporation Tax Law, in modified conformity to a credit allowed under federal law, allows a credit against taxes imposed by that law for increasing research activities, as described.This bill would make nonsubstantive changes to the provisions allowing that credit.The Corporation Tax Law imposes taxes upon a corporation doing business in this state, according to, or measured by, net income, as specified. The Corporation Tax Law, in modified conformity to a credit allowed under federal law, allows a credit against taxes imposed by that law for increasing research activities, as described.
This bill would make nonsubstantive changes to the provisions allowing that credit.
The Legislature finds and declares all of the following:
(a)Childhood cancer is the leading cause of disease-related death in children in the United States. Unlike many adult cancers, pediatric cancers are biologically distinct and require specialized research to develop effective treatments. Despite this, only 8 percent of federal cancer research funding is dedicated to childhood cancers, leaving a significant gap in resources needed for advancements in care.
(b)Many pediatric cancers, such as diffuse intrinsic pontine glioma (DIPG) and other rare brain tumors, have survival rates near 0 percent, with no significant treatment advancements in decades. For other childhood cancers, while the five-year survival rate is 83.3 percent, many survivors face lifelong health complications, including organ damage, secondary cancers, and cognitive impairments due to the toxic nature of current treatments. Unlike adult cancers, most pediatric cancers are not preventable, making research into safer and more effective therapies essential.
(c)The impact of childhood cancer extends beyond the patient, placing immense physical, emotional, and financial strain on families. Many parents leave jobs or relocate to access treatment, leading to financial hardship. In California, racial and ethnic disparities persist in pediatric cancer incidence and outcomes. Hispanic children have higher overall cancer rates than Black children (16.0 vs. 13.1 per 100,000), while White children experience the highest rates of brain and central nervous system tumors. These disparities highlight the urgent need for equitable access to research, treatment, and support services across all communities.
(d)It is the intent of the Legislature, in enacting this article, to establish a coordinated statewide funding mechanism to advance research, treatment, and support systems for pediatric cancer. This will support research by scientists and clinicians at California cancer research centers, hospitals, and universities to develop innovative therapies and improve access to clinical trials. By enacting the California Pediatric Cancer Research Voluntary Tax Contribution Fund, California can lead the way in pediatric cancer research, ultimately improving survival rates and quality of life for children diagnosed with this devastating disease.
SEC. 2.Article 3 (commencing with Section 18720) is added to Chapter 3 of Part 10.2 of Division 2 of the Revenue and Taxation Code, to read:3.California Pediatric Cancer Research Voluntary Tax Contribution Fund18720.(a)Any individual may designate on the tax return that a contribution in excess of the tax liability, if any, be made to the California Pediatric Cancer Research Voluntary Tax Contribution Fund, established pursuant to Section 18721. That designation is to be used as a voluntary checkoff on the tax return.
(b)The contributions shall be in full dollar amounts and may be made individually by each signatory on a joint return.
(c)A designation under subdivision (a) shall be made for any taxable year on the original return for that taxable year, and once made shall be irrevocable. In the event that payments and credits reported on the return, together with any other credits associated with the taxpayers account, do not exceed the taxpayers liability, the return shall be treated as though no designation has been made.
(d)In the event a taxpayer designates a contribution to more than one account or fund listed on the tax return, and the amount available for designation is insufficient to satisfy the total amount designated, the contribution shall be allocated among the designees on a pro rata basis.
(e)When another voluntary contribution designation is removed from the tax return, or as soon as space is available, whichever occurs first, the Franchise Tax Board shall revise the forms of the return to include a space labeled the California Pediatric Cancer Research Voluntary Tax Contribution Fund to allow for the designation permitted under subdivision (a). The forms shall also include in the instructions information that the contribution may be in the amount of one dollar ($1) or more and that the contribution shall be used to support research relating to the cure, screening, and treatment of pediatric cancers.
(f)A deduction shall be allowed under Article 6 (commencing with Section 17201) of Chapter 3 of Part 10 for any contribution made pursuant to subdivision (a).
18721.There is hereby established in the State Treasury the California Pediatric Cancer Research Voluntary Tax Contribution Fund to receive contributions made pursuant to Section 18720. The Franchise Tax Board shall notify the Controller of both the amount of money paid by taxpayers in excess of their tax liability and the amount of refund money that taxpayers have designated pursuant to Section 18720 to be transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund. The Controller shall transfer from the Personal Income Tax Fund to the California Pediatric Cancer Research Voluntary Tax Contribution Fund an amount not in excess of the sum of the amounts designated by individuals pursuant to Section 18720 for payment into that fund.
18722.(a)Notwithstanding Section 13340 of the Government Code, all money transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund shall be continuously appropriated and allocated as follows:
(1)To the Franchise Tax Board and the Controller for reimbursement of all costs incurred by the Franchise Tax Board and the Controller in connection with their duties under this article.
(2)To the Regents of the University of California for distribution of grants for the purposes of conducting research on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer. The Regents of the University of California may use up to 5 percent of the money allocated to them for administering and promoting the program.
(b)The Legislature requests the Regents of the University of California to report on its internet website the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, including, but not limited to, information regarding recipients of funds.
18723.(a)Except as otherwise provided in subdivision (b), this article shall remain operative only until January 1 of the seventh calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, and is repealed as of December 1 of that year.
(b)(1)By September 1 of the second calendar year and each subsequent calendar year that the California Pediatric Cancer Research Voluntary Tax Contribution Fund appears on the tax return, the Franchise Tax Board shall determine whether the amount of contributions estimated to be received during the calendar year will equal or exceed the minimum contribution amount for the calendar year pursuant to paragraph (3). The Franchise Tax Board shall estimate the amount of contributions to be received by using the actual amounts received and an estimate of the contributions that will be received by the end of that calendar year.
(2)If the Franchise Tax Board determines that the amount of the contributions estimated to be received during a calendar year will not at least equal the minimum contribution amount for the calendar year, this article is inoperative with respect to taxable years beginning on or after January 1 of that calendar year and is repealed on December 1 of that calendar year.
(3)For purposes of this section, the minimum contribution amount for a calendar year means two hundred fifty thousand dollars ($250,000).
(c)Notwithstanding the repeal of this article, any contribution amounts designated pursuant to this article prior to its repeal shall continue to be transferred and disbursed in accordance with this article as in effect immediately prior to that repeal.
The Legislature finds and declares all of the following:
(a)Childhood cancer is the leading cause of disease-related death in children in the United States. Unlike many adult cancers, pediatric cancers are biologically distinct and require specialized research to develop effective treatments. Despite this, only 8 percent of federal cancer research funding is dedicated to childhood cancers, leaving a significant gap in resources needed for advancements in care.
(b)Many pediatric cancers, such as diffuse intrinsic pontine glioma (DIPG) and other rare brain tumors, have survival rates near 0 percent, with no significant treatment advancements in decades. For other childhood cancers, while the five-year survival rate is 83.3 percent, many survivors face lifelong health complications, including organ damage, secondary cancers, and cognitive impairments due to the toxic nature of current treatments. Unlike adult cancers, most pediatric cancers are not preventable, making research into safer and more effective therapies essential.
(c)The impact of childhood cancer extends beyond the patient, placing immense physical, emotional, and financial strain on families. Many parents leave jobs or relocate to access treatment, leading to financial hardship. In California, racial and ethnic disparities persist in pediatric cancer incidence and outcomes. Hispanic children have higher overall cancer rates than Black children (16.0 vs. 13.1 per 100,000), while White children experience the highest rates of brain and central nervous system tumors. These disparities highlight the urgent need for equitable access to research, treatment, and support services across all communities.
(d)It is the intent of the Legislature, in enacting this article, to establish a coordinated statewide funding mechanism to advance research, treatment, and support systems for pediatric cancer. This will support research by scientists and clinicians at California cancer research centers, hospitals, and universities to develop innovative therapies and improve access to clinical trials. By enacting the California Pediatric Cancer Research Voluntary Tax Contribution Fund, California can lead the way in pediatric cancer research, ultimately improving survival rates and quality of life for children diagnosed with this devastating disease.
SEC. 2.Article 3 (commencing with Section 18720) is added to Chapter 3 of Part 10.2 of Division 2 of the Revenue and Taxation Code, to read:3.California Pediatric Cancer Research Voluntary Tax Contribution Fund18720.(a)Any individual may designate on the tax return that a contribution in excess of the tax liability, if any, be made to the California Pediatric Cancer Research Voluntary Tax Contribution Fund, established pursuant to Section 18721. That designation is to be used as a voluntary checkoff on the tax return.
(b)The contributions shall be in full dollar amounts and may be made individually by each signatory on a joint return.
(c)A designation under subdivision (a) shall be made for any taxable year on the original return for that taxable year, and once made shall be irrevocable. In the event that payments and credits reported on the return, together with any other credits associated with the taxpayers account, do not exceed the taxpayers liability, the return shall be treated as though no designation has been made.
(d)In the event a taxpayer designates a contribution to more than one account or fund listed on the tax return, and the amount available for designation is insufficient to satisfy the total amount designated, the contribution shall be allocated among the designees on a pro rata basis.
(e)When another voluntary contribution designation is removed from the tax return, or as soon as space is available, whichever occurs first, the Franchise Tax Board shall revise the forms of the return to include a space labeled the California Pediatric Cancer Research Voluntary Tax Contribution Fund to allow for the designation permitted under subdivision (a). The forms shall also include in the instructions information that the contribution may be in the amount of one dollar ($1) or more and that the contribution shall be used to support research relating to the cure, screening, and treatment of pediatric cancers.
(f)A deduction shall be allowed under Article 6 (commencing with Section 17201) of Chapter 3 of Part 10 for any contribution made pursuant to subdivision (a).
18721.There is hereby established in the State Treasury the California Pediatric Cancer Research Voluntary Tax Contribution Fund to receive contributions made pursuant to Section 18720. The Franchise Tax Board shall notify the Controller of both the amount of money paid by taxpayers in excess of their tax liability and the amount of refund money that taxpayers have designated pursuant to Section 18720 to be transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund. The Controller shall transfer from the Personal Income Tax Fund to the California Pediatric Cancer Research Voluntary Tax Contribution Fund an amount not in excess of the sum of the amounts designated by individuals pursuant to Section 18720 for payment into that fund.
18722.(a)Notwithstanding Section 13340 of the Government Code, all money transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund shall be continuously appropriated and allocated as follows:
(1)To the Franchise Tax Board and the Controller for reimbursement of all costs incurred by the Franchise Tax Board and the Controller in connection with their duties under this article.
(2)To the Regents of the University of California for distribution of grants for the purposes of conducting research on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer. The Regents of the University of California may use up to 5 percent of the money allocated to them for administering and promoting the program.
(b)The Legislature requests the Regents of the University of California to report on its internet website the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, including, but not limited to, information regarding recipients of funds.
18723.(a)Except as otherwise provided in subdivision (b), this article shall remain operative only until January 1 of the seventh calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, and is repealed as of December 1 of that year.
(b)(1)By September 1 of the second calendar year and each subsequent calendar year that the California Pediatric Cancer Research Voluntary Tax Contribution Fund appears on the tax return, the Franchise Tax Board shall determine whether the amount of contributions estimated to be received during the calendar year will equal or exceed the minimum contribution amount for the calendar year pursuant to paragraph (3). The Franchise Tax Board shall estimate the amount of contributions to be received by using the actual amounts received and an estimate of the contributions that will be received by the end of that calendar year.
(2)If the Franchise Tax Board determines that the amount of the contributions estimated to be received during a calendar year will not at least equal the minimum contribution amount for the calendar year, this article is inoperative with respect to taxable years beginning on or after January 1 of that calendar year and is repealed on December 1 of that calendar year.
(3)For purposes of this section, the minimum contribution amount for a calendar year means two hundred fifty thousand dollars ($250,000).
(c)Notwithstanding the repeal of this article, any contribution amounts designated pursuant to this article prior to its repeal shall continue to be transferred and disbursed in accordance with this article as in effect immediately prior to that repeal.
The Legislature finds and declares all of the following:
(a)Childhood cancer is the leading cause of disease-related death in children in the United States. Unlike many adult cancers, pediatric cancers are biologically distinct and require specialized research to develop effective treatments. Despite this, only 8 percent of federal cancer research funding is dedicated to childhood cancers, leaving a significant gap in resources needed for advancements in care.
(b)Many pediatric cancers, such as diffuse intrinsic pontine glioma (DIPG) and other rare brain tumors, have survival rates near 0 percent, with no significant treatment advancements in decades. For other childhood cancers, while the five-year survival rate is 83.3 percent, many survivors face lifelong health complications, including organ damage, secondary cancers, and cognitive impairments due to the toxic nature of current treatments. Unlike adult cancers, most pediatric cancers are not preventable, making research into safer and more effective therapies essential.
(c)The impact of childhood cancer extends beyond the patient, placing immense physical, emotional, and financial strain on families. Many parents leave jobs or relocate to access treatment, leading to financial hardship. In California, racial and ethnic disparities persist in pediatric cancer incidence and outcomes. Hispanic children have higher overall cancer rates than Black children (16.0 vs. 13.1 per 100,000), while White children experience the highest rates of brain and central nervous system tumors. These disparities highlight the urgent need for equitable access to research, treatment, and support services across all communities.
(d)It is the intent of the Legislature, in enacting this article, to establish a coordinated statewide funding mechanism to advance research, treatment, and support systems for pediatric cancer. This will support research by scientists and clinicians at California cancer research centers, hospitals, and universities to develop innovative therapies and improve access to clinical trials. By enacting the California Pediatric Cancer Research Voluntary Tax Contribution Fund, California can lead the way in pediatric cancer research, ultimately improving survival rates and quality of life for children diagnosed with this devastating disease.
SEC. 2.Article 3 (commencing with Section 18720) is added to Chapter 3 of Part 10.2 of Division 2 of the Revenue and Taxation Code, to read:3.California Pediatric Cancer Research Voluntary Tax Contribution Fund18720.(a)Any individual may designate on the tax return that a contribution in excess of the tax liability, if any, be made to the California Pediatric Cancer Research Voluntary Tax Contribution Fund, established pursuant to Section 18721. That designation is to be used as a voluntary checkoff on the tax return.
(b)The contributions shall be in full dollar amounts and may be made individually by each signatory on a joint return.
(c)A designation under subdivision (a) shall be made for any taxable year on the original return for that taxable year, and once made shall be irrevocable. In the event that payments and credits reported on the return, together with any other credits associated with the taxpayers account, do not exceed the taxpayers liability, the return shall be treated as though no designation has been made.
(d)In the event a taxpayer designates a contribution to more than one account or fund listed on the tax return, and the amount available for designation is insufficient to satisfy the total amount designated, the contribution shall be allocated among the designees on a pro rata basis.
(e)The When another voluntary contribution designation is removed from the tax return, or as soon as space is available, whichever occurs first, the Franchise Tax Board shall revise the forms of the return to include a space labeled the California Pediatric Cancer Research Voluntary Tax Contribution Fund to allow for the designation permitted under subdivision (a). The forms shall also include in the instructions information that the contribution may be in the amount of one dollar ($1) or more and that the contribution shall be used to support research relating to the cure, screening, and treatment of pediatric cancers.
(f)A deduction shall be allowed under Article 6 (commencing with Section 17201) of Chapter 3 of Part 10 for any contribution made pursuant to subdivision (a).
18721.There is hereby established in the State Treasury the California Pediatric Cancer Research Voluntary Tax Contribution Fund to receive contributions made pursuant to Section 18720. The Franchise Tax Board shall notify the Controller of both the amount of money paid by taxpayers in excess of their tax liability and the amount of refund money that taxpayers have designated pursuant to Section 18720 to be transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund. The Controller shall transfer from the Personal Income Tax Fund to the California Pediatric Cancer Research Voluntary Tax Contribution Fund an amount not in excess of the sum of the amounts designated by individuals pursuant to Section 18720 for payment into that fund.
18722.(a)Notwithstanding Section 13340 of the Government Code, all money transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund shall be continuously appropriated and allocated as follows:
(1)To the Franchise Tax Board and the Controller for reimbursement of all costs incurred by the Franchise Tax Board and the Controller in connection with their duties under this article.
(2)To the Regents of the University of California for distribution of grants for the purposes of conducting research on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer, and for reimbursement of any costs incurred by the regents for administering the grants authorized pursuant to this section. cancer. The Regents of the University of California may use up to 5 percent of the money allocated to them for administering and promoting the program.
(b)The Legislature requests the Regents of the University of California to report on its internet website the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, including, but not limited to, information regarding recipients of funds.
18723.(a)Except as otherwise provided in subdivision (b), this article shall remain operative only until January 1, 2033, and as of December 1 of that year is repealed. January 1 of the seventh calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, and is repealed as of December 1 of that year.
(b)(1)By September 1 of the second calendar year and each subsequent calendar year that the California Pediatric Cancer Research Voluntary Tax Contribution Fund appears on the tax return, the Franchise Tax Board shall determine whether the amount of contributions estimated to be received during the calendar year will equal or exceed the minimum contribution amount for the calendar year pursuant to paragraph (3). The Franchise Tax Board shall estimate the amount of contributions to be received by using the actual amounts received and an estimate of the contributions that will be received by the end of that calendar year.
(2)If the Franchise Tax Board determines that the amount of the contributions estimated to be received during a calendar year will not at least equal the minimum contribution amount for the calendar year, this article is inoperative with respect to taxable years beginning on or after January 1 of that calendar year and is repealed on December 1 of that calendar year.
(3)For purposes of this section, the minimum contribution amount for a calendar year means two hundred fifty thousand dollars ($250,000).
(c)Notwithstanding the repeal of this article, any contribution amounts designated pursuant to this article prior to its repeal shall continue to be transferred and disbursed in accordance with this article as in effect immediately prior to that repeal.
The Legislature finds and declares all of the following:
(a)Childhood cancer is the leading cause of disease-related death in children in the United States. Unlike many adult cancers, pediatric cancers are biologically distinct and require specialized research to develop effective treatments. Despite this, only 8 percent of federal cancer research funding is dedicated to childhood cancers, leaving a significant gap in resources needed for advancements in care.
(b)Many pediatric cancers, such as diffuse intrinsic pontine glioma (DIPG) and other rare brain tumors, have survival rates near 0 percent, with no significant treatment advancements in decades. For other childhood cancers, while the five-year survival rate is 83.3 percent, many survivors face lifelong health complications, including organ damage, secondary cancers, and cognitive impairments due to the toxic nature of current treatments. Unlike adult cancers, most pediatric cancers are not preventable, making research into safer and more effective therapies essential.
(c)The impact of childhood cancer extends beyond the patient, placing immense physical, emotional, and financial strain on families. Many parents leave jobs or relocate to access treatment, leading to financial hardship. In California, racial and ethnic disparities persist in pediatric cancer incidence and outcomes. Hispanic children have higher overall cancer rates than Black children (16.0 vs. 13.1 per 100,000), while White children experience the highest rates of brain and central nervous system tumors. These disparities highlight the urgent need for equitable access to research, treatment, and support services across all communities.
(d)It is the intent of the Legislature, in enacting this article, to establish a coordinated statewide funding mechanism to advance research, treatment, and support systems for pediatric cancer. This will support research by scientists and clinicians at California cancer research centers, hospitals, and universities to develop innovative therapies and improve access to clinical trials. By enacting the California Pediatric Cancer Research Voluntary Tax Contribution Fund, California can lead the way in pediatric cancer research, ultimately improving survival rates and quality of life for children diagnosed with this devastating disease.
SEC. 2.Article 3 (commencing with Section 18720) is added to Chapter 3 of Part 10.2 of Division 2 of the Revenue and Taxation Code, to read:3.California Pediatric Cancer Research Voluntary Tax Contribution Fund18720.(a)Any individual may designate on the tax return that a contribution in excess of the tax liability, if any, be made to the California Pediatric Cancer Research Voluntary Tax Contribution Fund, established pursuant to Section 18721. That designation is to be used as a voluntary checkoff on the tax return.
(b)The contributions shall be in full dollar amounts and may be made individually by each signatory on a joint return.
(c)A designation under subdivision (a) shall be made for any taxable year on the original return for that taxable year, and once made shall be irrevocable. In the event that payments and credits reported on the return, together with any other credits associated with the taxpayers account, do not exceed the taxpayers liability, the return shall be treated as though no designation has been made.
(d)In the event a taxpayer designates a contribution to more than one account or fund listed on the tax return, and the amount available for designation is insufficient to satisfy the total amount designated, the contribution shall be allocated among the designees on a pro rata basis.
(e)The Franchise Tax Board shall revise the forms of the return to include a space labeled the California Pediatric Cancer Research Voluntary Tax Contribution Fund to allow for the designation permitted under subdivision (a). The forms shall also include in the instructions information that the contribution may be in the amount of one dollar ($1) or more and that the contribution shall be used to support research relating to the cure, screening, and treatment of pediatric cancers.
(f)A deduction shall be allowed under Article 6 (commencing with Section 17201) of Chapter 3 of Part 10 for any contribution made pursuant to subdivision (a).
18721.There is hereby established in the State Treasury the California Pediatric Cancer Research Voluntary Tax Contribution Fund to receive contributions made pursuant to Section 18720. The Franchise Tax Board shall notify the Controller of both the amount of money paid by taxpayers in excess of their tax liability and the amount of refund money that taxpayers have designated pursuant to Section 18720 to be transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund. The Controller shall transfer from the Personal Income Tax Fund to the California Pediatric Cancer Research Voluntary Tax Contribution Fund an amount not in excess of the sum of the amounts designated by individuals pursuant to Section 18720 for payment into that fund.
18722.(a)Notwithstanding Section 13340 of the Government Code, all money transferred to the California Pediatric Cancer Research Voluntary Tax Contribution Fund shall be continuously appropriated and allocated as follows:
(1)To the Franchise Tax Board and the Controller for reimbursement of all costs incurred by the Franchise Tax Board and the Controller in connection with their duties under this article.
(2)To the Regents of the University of California for distribution of grants for the purposes of conducting research on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer, and for reimbursement of any costs incurred by the regents for administering the grants authorized pursuant to this section.
(b)The Legislature requests the Regents of the University of California to report on its internet website the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, including, but not limited to, information regarding recipients of funds.
18723.(a)Except as otherwise provided in subdivision (b), this article shall remain operative only until January 1, 2033, and as of December 1 of that year is repealed.
(b)(1)By September 1 of the second calendar year and each subsequent calendar year that the California Pediatric Cancer Research Voluntary Tax Contribution Fund appears on the tax return, the Franchise Tax Board shall determine whether the amount of contributions estimated to be received during the calendar year will equal or exceed the minimum contribution amount for the calendar year pursuant to paragraph (3). The Franchise Tax Board shall estimate the amount of contributions to be received by using the actual amounts received and an estimate of the contributions that will be received by the end of that calendar year.
(2)If the Franchise Tax Board determines that the amount of the contributions estimated to be received during a calendar year will not at least equal the minimum contribution amount for the calendar year, this article is inoperative with respect to taxable years beginning on or after January 1 of that calendar year and is repealed on December 1 of that calendar year.
(3)For purposes of this section, the minimum contribution amount for a calendar year means two hundred fifty thousand dollars ($250,000).
(c)Notwithstanding the repeal of this article, any contribution amounts designated pursuant to this article prior to its repeal shall continue to be transferred and disbursed in accordance with this article as in effect immediately prior to that repeal.
SECTION 1.Section 23609 of the Revenue and Taxation Code is amended to read:23609.For each taxable year beginning on or after January 1, 1987, there shall be allowed as a credit against the tax, as defined by Section 23036, an amount determined in accordance with Section 41 of the Internal Revenue Code, relating to credit for increasing research activities, except as follows:(a)For each taxable year beginning before January 1, 1997, both of the following modifications shall apply:(1)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 8 percent.(2)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 12 percent.(b)(1)For each taxable year beginning on or after January 1, 1997, and before January 1, 1999, both of the following modifications shall apply:(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 11 percent.(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.(2)For each taxable year beginning on or after January 1, 1999, and before January 1, 2000, both of the following shall apply:(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 12 percent.(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.(3)For each taxable year beginning on or after January 1, 2000, both of the following shall apply:(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 15 percent.(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.(c)(1)With respect to any expense paid or incurred after the operative date of Section 6378, Section 41(b)(1) of the Internal Revenue Code, relating to qualified research expenses, is modified to exclude from the definition of qualified research expense any amount paid or incurred for tangible personal property that is eligible for the exemption from sales or use tax provided by Section 6378.(2)Qualified research and basic research shall include only research conducted in California.(d)The provisions of Section 41(e)(7)(A) of the Internal Revenue Code, relating to basic research, shall be modified so that basic research, for purposes of this section, includes any basic or applied research including scientific inquiry or original investigation for the advancement of scientific or engineering knowledge or the improved effectiveness of commercial products, except that the term does not include any of the following:(1)Basic research conducted outside California.(2)Basic research in the social sciences, arts, or humanities.(3)Basic research for the purpose of improving a commercial product if the improvements relate to style, taste, cosmetic, or seasonal design factors.(4)Any expenditure paid or incurred for the purpose of ascertaining the existence, location, extent, or quality of any deposit of ore or other mineral (including oil and gas).(e)(1)In the case of a taxpayer engaged in any biopharmaceutical research activities that are described in codes 2833 to 2836, inclusive, or any research activities that are described in codes 3826, 3829, or 3841 to 3845, inclusive, of the Standard Industrial Classification (SIC) Manual published by the United States Office of Management and Budget, 1987 edition, or any other biotechnology research and development activities, the provisions of Section 41(e)(6) of the Internal Revenue Code, relating to qualified organization, shall be modified to include both of the following:(A)A qualified organization as described in Section 170(b)(1)(A)(iii) of the Internal Revenue Code and owned by an institution of higher education as described in Section 3304(f) of the Internal Revenue Code, relating to definition of institution of higher education.(B)A charitable research hospital owned by an organization that is described in Section 501(c)(3) of the Internal Revenue Code, is exempt from taxation under Section 501(a) of the Internal Revenue Code, relating to exemption from taxation, is not a private foundation, is designated a specialized laboratory cancer center, and has received Clinical Cancer Research Center status from the National Cancer Institute.(2)For purposes of this subdivision:(A)Biopharmaceutical research activities means those activities that use organisms or materials derived from organisms, and their cellular, subcellular, or molecular components, in order to provide pharmaceutical products for human or animal therapeutics and diagnostics. Biopharmaceutical activities make use of living organisms to make commercial products, as opposed to pharmaceutical activities that make use of chemical compounds to produce commercial products.(B)Other biotechnology research and development activities means research and development activities consisting of the application of recombinant DNA technology to produce commercial products, as well as research and development activities regarding pharmaceutical delivery systems designed to provide a measure of control over the rate, duration, and site of pharmaceutical delivery.(f)In the case where the credit allowed by this section exceeds the tax, the excess may be carried over to reduce the tax in the following year, and succeeding years if necessary, until the credit has been exhausted.(g)For each taxable year beginning on or after January 1, 1998, the reference to Section 501(a) in Section 41(b)(3)(C) of the Internal Revenue Code, relating to amounts paid to certain research consortia, is modified to read this part or Part 10 (commencing with Section 17001).(h)(1)For each taxable year beginning on or after January 1, 2000:(A)The reference to 3 percent in Section 41(c)(4)(A)(i) of the Internal Revenue Code is modified to read one and forty-nine hundredths of one percent.(B)The reference to 4 percent in Section 41(c)(4)(A)(ii) of the Internal Revenue Code is modified to read one and ninety-eight hundredths of one percent.(C)The reference to 5 percent in Section 41(c)(4)(A)(iii) of the Internal Revenue Code is modified to read two and forty-eight hundredths of one percent.(2)Section 41(c)(4)(B) of the Internal Revenue Code, relating to election, shall not apply and in lieu thereof an election under Section 41(c)(4)(A) of the Internal Revenue Code, relating to in general, may be made for any taxable year of the taxpayer beginning on or after January 1, 1998. That election shall apply to the taxable year for which made and all succeeding taxable years unless revoked with the consent of the Franchise Tax Board.(3)Section 41(c)(7) of the Internal Revenue Code, relating to gross receipts, is modified to take into account only those gross receipts from the sale of property held primarily for sale to customers in the ordinary course of the taxpayers trade or business that is delivered or shipped to a purchaser within this state, regardless of f.o.b. point or any other condition of the sale.(4)Section 41(c)(5) of the Internal Revenue Code, relating to election of alternative simplified credit, shall not apply.(i)Section 41(h) of the Internal Revenue Code, relating to termination, shall not apply.(j)Section 41(g) of the Internal Revenue Code, relating to special rule for pass-thru of credit, is modified by each of the following:(1)The last sentence shall not apply.(2)If the amount determined under Section 41(a) of the Internal Revenue Code, relating to general rule, for any taxable year exceeds the limitation of Section 41(g) of the Internal Revenue Code, that amount may be carried over to other taxable years under the rules of subdivision (f), except that the limitation of Section 41(g) of the Internal Revenue Code, relating to special rule for pass-thru of credit, shall be taken into account in each subsequent taxable year.(k)Section 41(a)(3) of the Internal Revenue Code shall not apply.(l)Section 41(b)(3)(D) of the Internal Revenue Code, relating to amounts paid to eligible small businesses, universities, and federal laboratories, shall not apply.(m)Section 41(f)(6) of the Internal Revenue Code, relating to energy research consortium, shall not apply.For each taxable year beginning on or after January 1, 1987, there shall be allowed as a credit against the tax (as tax, as defined by Section 23036) 23036, an amount determined in accordance with Section 41 of the Internal Revenue Code, relating to credit for increasing research activities, except as follows:
(a)For each taxable year beginning before January 1, 1997, both of the following modifications shall apply:
(1)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 8 percent.
(2)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 12 percent.
(b)(1)For each taxable year beginning on or after January 1, 1997, and before January 1, 1999, both of the following modifications shall apply:
(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 11 percent.
(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.
(2)For each taxable year beginning on or after January 1, 1999, and before January 1, 2000, both of the following shall apply:
(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 12 percent.
(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.
(3)For each taxable year beginning on or after January 1, 2000, both of the following shall apply:
(A)The reference to 20 percent in Section 41(a)(1) of the Internal Revenue Code is modified to read 15 percent.
(B)The reference to 20 percent in Section 41(a)(2) of the Internal Revenue Code is modified to read 24 percent.
(c)(1)With respect to any expense paid or incurred after the operative date of Section 6378, Section 41(b)(1) of the Internal Revenue Code Code, relating to qualified research expenses, is modified to exclude from the definition of qualified research expense any amount paid or incurred for tangible personal property that is eligible for the exemption from sales or use tax provided by Section 6378.
(2)Qualified research and basic research shall include only research conducted in California.
(d)The provisions of Section 41(e)(7)(A) of the Internal Revenue Code, relating to basic research, shall be modified so that basic research, for purposes of this section, includes any basic or applied research including scientific inquiry or original investigation for the advancement of scientific or engineering knowledge or the improved effectiveness of commercial products, except that the term does not include any of the following:
(1)Basic research conducted outside California.
(2)Basic research in the social sciences, arts, or humanities.
(3)Basic research for the purpose of improving a commercial product if the improvements relate to style, taste, cosmetic, or seasonal design factors.
(4)Any expenditure paid or incurred for the purpose of ascertaining the existence, location, extent, or quality of any deposit of ore or other mineral (including oil and gas).
(e)(1)In the case of a taxpayer engaged in any biopharmaceutical research activities that are described in codes 2833 to 2836, inclusive, or any research activities that are described in codes 3826, 3829, or 3841 to 3845, inclusive, of the Standard Industrial Classification (SIC) Manual published by the United States Office of Management and Budget, 1987 edition, or any other biotechnology research and development activities, the provisions of Section 41(e)(6) of the Internal Revenue Code Code, relating to qualified organization, shall be modified to include both of the following:
(A)A qualified organization as described in Section 170(b)(1)(A)(iii) of the Internal Revenue Code and owned by an institution of higher education as described in Section 3304(f) of the Internal Revenue Code. Code, relating to definition of institution of higher education.
(B)A charitable research hospital owned by an organization that is described in Section 501(c)(3) of the Internal Revenue Code, is exempt from taxation under Section 501(a) of the Internal Revenue Code, relating to exemption from taxation, is not a private foundation, is designated a specialized laboratory cancer center, and has received Clinical Cancer Research Center status from the National Cancer Institute.
(2)For purposes of this subdivision:
(A)Biopharmaceutical research activities means those activities that use organisms or materials derived from organisms, and their cellular, subcellular, or molecular components, in order to provide pharmaceutical products for human or animal therapeutics and diagnostics. Biopharmaceutical activities make use of living organisms to make commercial products, as opposed to pharmaceutical activities that make use of chemical compounds to produce commercial products.
(B)Other biotechnology research and development activities means research and development activities consisting of the application of recombinant DNA technology to produce commercial products, as well as research and development activities regarding pharmaceutical delivery systems designed to provide a measure of control over the rate, duration, and site of pharmaceutical delivery.
(f)In the case where the credit allowed by this section exceeds the tax, the excess may be carried over to reduce the tax in the following year, and succeeding years if necessary, until the credit has been exhausted.
(g)For each taxable year beginning on or after January 1, 1998, the reference to Section 501(a) in Section 41(b)(3)(C) of the Internal Revenue Code, relating to contract research expenses, amounts paid to certain research consortia, is modified to read this part or Part 10 (commencing with Section 17001).
(h)(1)For each taxable year beginning on or after January 1, 2000:
(A)The reference to 3 percent in Section 41(c)(4)(A)(i) of the Internal Revenue Code is modified to read one and forty-nine hundredths of one percent.
(B)The reference to 4 percent in Section 41(c)(4)(A)(ii) of the Internal Revenue Code is modified to read one and ninety-eight hundredths of one percent.
(C)The reference to 5 percent in Section 41(c)(4)(A)(iii) of the Internal Revenue Code is modified to read two and forty-eight hundredths of one percent.
(2)Section 41(c)(4)(B) of the Internal Revenue Code, relating to election, shall not apply and in lieu thereof an election under Section 41(c)(4)(A) of the Internal Revenue Code Code, relating to in general, may be made for any taxable year of the taxpayer beginning on or after January 1, 1998. That election shall apply to the taxable year for which made and all succeeding taxable years unless revoked with the consent of the Franchise Tax Board.
(3)Section 41(c)(7) of the Internal Revenue Code, relating to gross receipts, is modified to take into account only those gross receipts from the sale of property held primarily for sale to customers in the ordinary course of the taxpayers trade or business that is delivered or shipped to a purchaser within this state, regardless of f.o.b. point or any other condition of the sale.
(4)Section 41(c)(5) of the Internal Revenue Code, relating to election of the alternative simplified credit, shall not apply.
(i)Section 41(h) of the Internal Revenue Code, relating to termination, shall not apply.
(j)Section 41(g) of the Internal Revenue Code, relating to special rule for passthrough pass-thru of credit, is modified by each of the following:
(1)The last sentence shall not apply.
(2)If the amount determined under Section 41(a) of the Internal Revenue Code Code, relating to general rule, for any taxable year exceeds the limitation of Section 41(g) of the Internal Revenue Code, that amount may be carried over to other taxable years under the rules of subdivision (f), except that the limitation of Section 41(g) of the Internal Revenue Code Code, relating to special rule for pass-thru of credit, shall be taken into account in each subsequent taxable year.
(k)Section 41(a)(3) of the Internal Revenue Code shall not apply.
(l)Section 41(b)(3)(D) of the Internal Revenue Code, relating to amounts paid to eligible small businesses, universities, and federal laboratories, shall not apply.
(m)Section 41(f)(6) of the Internal Revenue Code, relating to energy research consortium, shall not apply.
|
Date
|
Status
|
|---|---|
| Jul 28, 2025 | Chaptered by Secretary of State - Chapter 63, Statutes of 2025. |
| Jul 28, 2025 | Approved by the Governor. |
| Jul 15, 2025 | Enrolled and presented to the Governor at 3:30 p.m. |
| Jul 10, 2025 | In Assembly. Ordered to Engrossing and Enrolling. |
| Jul 10, 2025 | Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0. Page 2042.). |
| Jul 8, 2025 | Read second time. Ordered to Consent Calendar. |
| Jul 7, 2025 | From committee: Be ordered to second reading file pursuant to Senate Rule 28.8 and ordered to Consent Calendar. |
| Jun 25, 2025 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 5. Noes 0.) (June 25). Re-referred to Com. on APPR. |
| May 14, 2025 | Referred to Com. on REV. & TAX. |
| May 6, 2025 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 5, 2025 | Read third time. Passed. Ordered to the Senate. (Ayes 76. Noes 0. Page 1430.) |
| May 1, 2025 | Read second time. Ordered to third reading. |
| Apr 30, 2025 | From committee: Do pass. (Ayes 14. Noes 0.) (April 30). |
| Apr 22, 2025 | Re-referred to Com. on APPR. |
| Apr 21, 2025 | Read second time and amended. |
| Apr 10, 2025 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 6. Noes 0.) (April 7). |
| Mar 25, 2025 | Re-referred to Com. on REV. & TAX. |
| Mar 24, 2025 | Referred to Com. on REV. & TAX. |
| Mar 24, 2025 | From committee chair, with author's amendments: Amend, and re-refer to Com. on REV. & TAX. Read second time and amended. |
| Feb 15, 2025 | From printer. May be heard in committee March 17. |
| Feb 14, 2025 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jul 10, 2025 | Consent Calendar 2nd AB703 Lee | Senate Floor |
Passed |
|
| Jun 25, 2025 | Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar | Senate Standing Committee on Revenue and Taxation |
Passed |
|
| May 5, 2025 | AB 703 Lee Assembly Third Reading | Assembly Floor |
Passed |
|
| Apr 30, 2025 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 7, 2025 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Revenue and Taxation |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| American Cancer Society Cancer Action Network | ** Support | |
| California Life Sciences | ** Support | |
| Neev Kolte & Brave Ronil Foundation | ** Support | |
| University of California | ** Support |
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 703 |
CONSENT
Bill No: AB 703
Author: Lee (D)
Amended: 4/21/25 in Assembly
Vote: 21
SENATE REVENUE AND TAXATION COMMITTEE: 5-0, 6/25/25
AYES: McNerney, Valladares, Ashby, Grayson, Umberg
ASSEMBLY FLOOR: 76-0, 5/5/25 - See last page for vote
SUBJECT: California Pediatric Cancer Research Voluntary Tax Contribution Fund
SOURCE: Neev Kolte & Brave Ronil Foundation
DIGEST:
This bill (1) establishes the California Pediatric Cancer Research Voluntary Tax Contribution Fund and (2) authorizes a taxpayer to make a voluntary contribution to the fund on their state personal income tax return from tax year 2025 to 2032.
ANALYSIS:
Existing law:
- Allows taxpayers to contribute money from their own resources in excess of the amount they owe in taxes to Voluntary Contribution Funds (VCF) by checking a box on their state Personal Income Tax (PIT) return.
- Establishes 18 VCFs on the PIT Return.
- Generally requires the Franchise Tax Board (FTB) to remove a VCF due to a sunset provision or if the VCF fails to meet the statutory minimum contribution amount.
- Generally requires FTB to annually determine whether estimated contributions to each VCF will exceed $250,000 to remain on the PIT form.
- Provides that after a taxpayer contributes to a VCF, the FTB deposits all contributions, minus its administration costs, into a fund named for the VCF.
- Requires that VCFs meet certain best practices:
- Include “voluntary tax contribution” in the fund name;
- Requires the administering agency’s internet website to report specific data related to the usage of the amounts received from a VCF;
- Be repealed following January 1 of the seventh calendar year following the first appearance of the contribution on the tax return and be repealed as of December 1 of that year.
This bill:
- Establishes the California Pediatric Cancer Research Voluntary Tax Contribution Fund.
- Authorizes a taxpayer to make a voluntary contribution to the fund on their state PIT return from tax year 2025 to 2032, if the fund meets the minimum contribution amount of $250,000 annually.
- Directs that contributions to the fund to be allocated to the Regents of the University of California for the distribution of research grants on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer.
- Authorizes the Regents of the University of California (UC) to use up to 5% of the money for administering and promoting the program.
Background
Pediatric cancer. While pediatric cancer is rare, it is the leading cause of death by disease after infancy among children in the United States. In 2024, it was estimated that 14,910 children ages 0-19 in the United States would be diagnosed with cancer, and 1,590 would die of the disease. As of 2021 (the most recent data available), there are approximately 511,793 pediatric cancer survivors in the United States. 80% of pediatric cancer patients in the United States are cared for at a children’s cancer center affiliated with the National Cancer Institute-supported Children’s Oncology Group. The University of California, San Francisco, UC Los Angeles, UC San Diego, UC Davis, and UC Irvine have COG-affiliated NCI-designated Comprehensive Cancer Centers.
FISCAL EFFECT: Appropriation: Yes Fiscal Com.: Yes Local: No
Senate Rule 28.8
SUPPORT: (Verified 7/7/25)
Neev Kolte & Brave Ronil Foundation (Co-Source)
American Cancer Society Cancer Action Network (Co-Source)
California Life Sciences
University of California
OPPOSITION: (Verified 7/7/25)
None received
ARGUMENTS IN SUPPORT: According to the author, “Cancer is the leading cause of death by disease for children in the United States. Each year, approximately 15,000 children are diagnosed with cancer, and tragically, 1 in 5 do not survive. Those who do survive often develop chronic conditions or severe illness due to treatment. Despite these alarming statistics, only 4% of federal funding goes towards pediatric cancer research. AB 703 establishes the Pediatric Cancer Research Voluntary Contribution Fund, which will allow Californians to donate towards pediatric cancer research, and positions our state as a leader in the fight against childhood cancer.”
ASSEMBLY FLOOR: 76-0, 5/5/25
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Flora, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO VOTE RECORDED: Bains, Ellis, Solache
Prepared by: Haley Summers / REV. & TAX. / (916) 651-4117
7/9/25 16:03:29
SENATE COMMITTEE ON REVENUE AND TAXATION
Senator Jerry McNerney, Chair
2025 - 2026 Regular
Bill No: | AB 703 | Hearing Date: | 6/25/25 |
Author: | Lee | Tax Levy: | No |
Version: | 4/21/25 | Fiscal: | Yes |
Consultant: | Summers | ||
California Pediatric Cancer Research Voluntary Tax Contribution Fund
Assembly Bill 703 establishes the California Pediatric Cancer Research Voluntary Tax Contribution Fund and authorizes a taxpayer to make a voluntary contribution to the fund on their state personal income tax return from tax year 2025 to 2032.
Background
Voluntary Tax Contribution Funds. California allows taxpayers to contribute money towards voluntary contribution funds (VCFs), commonly called “check-offs,” on their Personal Income Tax (PIT) return. Taxpayers may contribute money to one or more of these VCFs from the excess of the amount they owe in taxes and can claim a deduction for the year the contribution is made. Their contribution to a VCF is only made if their tax payments and credits exceed the taxes they owe to the state. Taxpayers can voluntarily contribute to one or several of the 18 organizations on their PIT return. These organizations include nonprofits that work on disease, natural resource conservation, and more.
The Legislature adds each VCF individually to PIT return forms through legislation. With a few exceptions, VCFs remain on the return until the Franchise Tax Board (FTB) removes the VCF due to a sunset provision or the VCF fails to meet the statutory minimum contribution amount. By September 1 of each calendar year, the FTB must determine whether estimated contributions to specified funds will be less than the minimum contribution amount required for that calendar year. If FTB estimates a fund will fail to meet the minimum contribution amount for a calendar year, the fund is repealed on January 1 of the following calendar year. In general, the annual minimum contribution amount is $250,000, beginning the fund’s second year, with some adjusted for inflation. The VCFs below do not have a minimum contribution requirement:
- California Firefighters’ Memorial Foundation Fund;
- California Peace Officer Memorial Foundation Fund;
- California Senior Citizen Advocacy Voluntary Tax Contribution Fund; and
- California Seniors Special Fund.
As of May 2025, there are 18 active VCFs. The contributions to these VCF during the last taxable year were as follows:
Alzheimer's Disease and Related Dementia | $466,637 |
California ALS Research Network | New VCF |
California Breast Cancer Research | $364,902 |
California Cancer Research | $362,544 |
California Firefighters' Memorial | $152,010 |
California Peace Officer Memorial Foundation | $100,521 |
California Sea Otter | $254,601 |
California Senior Citizen Advocacy | $98,438 |
California Seniors Special Fund | $109,504 |
Emergency Food for Families | $464,470** |
Keep Arts in Schools | $243,539 |
Mental Health Crisis Prevention | $321,308 |
Native California Wildlife Rehabilitation | $288,353 |
Prevention of Animal Homelessness and Cruelty | New VCF |
Protect Our Coast and Oceans | $256,175 |
Rare and Endangered Species Preservation | $370,111 |
School Supplies for Homeless Children | $519,637* |
State Parks Protection Fund/Parks Pass Purchase | $484,648 |
2024 TOTAL | $4,857,398 |
2024 Average | $303,587 |
* Most Popular 2024 |
After a taxpayer contributes to a VCF, the FTB deposits all contributions, minus its administration costs, into a fund named for the VCF. State agencies administer most VCF funds to fund the purpose outlined in the legislation that placed the VCF on the PIT form. For other VCFs, the State Controller’s office allocates taxpayer contributions directly to the private organization without going through an administrative agency. For example, the State Controller’s office directly passes taxpayer contributions to the California Fire Foundation.
Senate Bill 1476. In December 2015, the Senate Committee on Governance and Finance held an oversight hearing on VCFs. The Committee identified best practices and reforms needed to ensure the state allocates taxpayer contributions toward charitable purposes transparently and in a timely manner. In 2016, the Legislature enacted SB 1476 (Committee on Governance and Finance), which used those best practices to establish general provisions for all VCFs enacted on or extended after January 2, 2017. Specifically, the bill required of VCFs:
- The words “voluntary tax contribution” must be included in the fund's name;
- The administering agency’s website shall report specific data related to the usage of the amounts received via voluntary contribution;
- A voluntary contribution fund must receive a minimum contribution of $250,000 for the second calendar year after it first appears on the tax return and each year after that to remain on the tax return; and
- A voluntary tax contribution would remain in effect only until January 1 of the seventh calendar year following the first appearance of the contribution on the tax return and be repealed as of December 1 of that year.
Pediatric cancer. While pediatric cancer is rare, it is the leading cause of death by disease after infancy among children in the United States.[1] In 2024, it was estimated that 14,910 children ages 0-19 in the United States would be diagnosed with cancer, and 1,590 would die of the disease.[2] As of 2021 (the most recent data available), there are approximately 511,793 pediatric cancer survivors in the United States.[3] 80% of pediatric cancer patients in the United States are cared for at a children’s cancer center affiliated with the National Cancer Institute (NCI)-supported Children’s Oncology Group (COG).[4] The University of California (UC), San Francisco, UC Los Angeles, UC San Diego, UC Davis, and UC Irvine have COG-affiliated NCI-designated Comprehensive Cancer Centers.[5]
The Neev Kolte & Brave Ronil Foundation want to establish a VCF where the contributions to the fund will be used to advance research, treatment, and support systems for pediatric cancer through grants administered by the Regents of the University of California.
Proposed Law
Assembly Bill 703 establishes the California Pediatric Cancer Research Voluntary Tax Contribution Fund and authorizes a taxpayer to make a voluntary contribution to the fund on their state personal income tax return from tax year 2025 to 2032, if the fund meets the minimum contribution amount of $250,000 annually.
Contributions to this fund are allocated to the Regents of the University of California for the distribution of grants for the purposes of conducting research on the causes and treatments for pediatric cancer and expanding community-based education on pediatric cancer. The bill also authorizes the Regents of the University of California to use up to 5% of the money for administering and promoting the program.
State Revenue Impact
FTB estimates AB 703 will result in a revenue loss of $6,000 in Fiscal Year (FY) 2026-27 and $6,000 in FY 2027-28.
Comments
- Purpose of the bill. According to the author, “Cancer is the leading cause of death by disease for children in the United States. Each year, approximately 15,000 children are diagnosed with cancer, and tragically, 1 in 5 do not survive. Those who do survive often develop chronic conditions or severe illness due to treatment. Despite these alarming statistics, only 4% of federal funding goes towards pediatric cancer research. AB 703 establishes the Pediatric Cancer Research Voluntary Contribution Fund, which will allow Californians to donate towards pediatric cancer research, and positions our state as a leader in the fight against childhood cancer.”
- Many worthy causes. Today, the PIT return contains 18 VCFs. Even though the Legislature has added many VCFs on the return, the total contribution to this fund has remained fairly consistent. As a result, extending current or adding new ones may make it more difficult for each to meet its minimum contribution requirement.
- SB 1476 requirements. This fund meets the best practices outlined in SB 1476 detailed above.
- Related VCFs. As noted in the chart in the background section, there are two other active cancer-related VCFs: the California Breast Cancer Research VCF and the California Cancer Research VCF. Additionally, three other cancer-related VCFs were previously enacted but have since been repealed: the California Ovarian Cancer Research Fund, the California Prostate Cancer Research Fund, and the California Colorectal Cancer Prevention Fund.
- Vital research. The presence of skilled scientists and clinicians, along with robust funding, enables California to discover breakthrough treatments that benefit children with cancer both within the state and beyond. Funding plays a crucial role in attracting, retaining, and supporting talented physician-researchers. By investing in these efforts through grants, California can sustain its leadership in pediatric oncology research.
- Related Legislation. The Committee will also consider AB 829 (Sharp-Collins, 2025) at its June 25, 2025, hearing, which would establish the Parkinson’s Disease Research Voluntary Tax Contribution Fund.
Assembly Actions
Assembly Revenue & Taxation Committee: 6-0
Assembly Appropriations Committee: 14-0
Assembly Floor: 76-0
Support and Opposition
(6/19/2025)
Support: Neev Kolte & Brave Ronil Foundation (Sponsor)
American Cancer Society Cancer Action Network (Co-Sponsor)
California Life Sciences
University of California
Opposition: None received.
-- END --
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians 2024; 74(1):12–49, from https://pubmed.ncbi.nlm.nih.gov/38230766/. ↑
Id. ↑
National Cancer Institute. (2024). NCCR Explorer: National Childhood Cancer Registry Explorer. National Institutes of Health. Retrieved May 15, 2025, from https://nccrexplorer.ccdi.cancer.gov/application.html?site=1&data_type=5&graph_type=11&compareBy=sex&chk_sex_1=1&series=9&age_at_prev=1&advopt_precision=1&hdn_view=1&advopt_display=2#resultsRegion1. ↑
Children’s Oncology Group. (2023). About Us. https://www.childrensoncologygroup.org/about. ↑
UCSF Brain Tumor Center. (n.d.). Pediatric brain tumor research. University of California, San Francisco. Retrieved May 15, 2025, from https://braintumorcenter.ucsf.edu/research/pediatric-brain-tumor-research; UCLA Clinical and Translational Science Institute. (n.d.). Jonsson Comprehensive Cancer Center (JCCC). University of California, Los Angeles. Retrieved May 15, 2025, from https://ctsi.ucla.edu/jonsson-comprehensive-cancer-center-jccc; UC San Diego Health. (n.d.). Pediatric radiation therapy. University of California San Diego. Retrieved May 19, 2025, from https://health.ucsd.edu/care/cancer/treatments/radiation-therapy-radiosurgery/pediatric/; Rady Children's Hospital-San Diego. (n.d.). Research and clinical trials. Retrieved May 15, 2025, from https://www.rchsd.org/programs-services/cancer-blood-disorders/research-and-clinical-trials/; UCI Health. (n.d.). Chao Family Comprehensive Cancer Center. Retrieved May 19, 2025, from https://health.ucdavis.edu/cancer/pediatric-cancer-care/. ↑
ASSEMBLY THIRD READING
ATR Bill Id:AB 703
Author:(Lee)
As Amended Ver:April 21, 2025
Majority vote
SUMMARY
Authorizes the addition of the California Pediatric Cancer Research Voluntary Tax Contribution Fund (Fund) as a voluntary contribution fund (VCF) on the personal income tax (PIT) return.
Major Provisions
- Establishes the Fund in the State Treasury.
- Provides that all money in the Fund shall be continuously appropriated and allocated to the:
- Franchise Tax Board (FTB) and the State Controller for reimbursement of all administrative costs incurred; and,
- Regents of the University of California for distribution of grants to conduct research on the causes and treatments for pediatric cancer and to expand community-based education on pediatric cancer.
- Provides that, except as otherwise specified, the Fund's statutory provisions shall remain in effect only until January 1 of the seventh calendar year following the Fund's first appearance on the PIT return.
- Requires the Fund to meet a standard minimum contribution amount of $250,000 to remain in effect.
COMMENTS
- So many causes, so little space: There are countless worthy causes that would benefit from the inclusion of a VCF on the state's income tax returns. At the same time, space on the returns is limited. Thus, it could be argued that the current system for adding VCFs to the form is subjective and essentially rewards organizations and causes that can convince the Legislature to include their fund on the PIT return.
- What would this bill do? This bill would establish the Fund as a means of providing a dedicated funding source for pediatric cancer research. Specifically, this bill calls for Fund moneys to be allocated to the Regents for the distribution of grants. These grants, in turn, would be for pediatric cancer research and for expanding community-based education on pediatric cancer.
According to the Author
The author has provided the following statement in support of this bill:
Cancer is the leading cause of death by disease for children in the United States. Each year, approximately 15,000 children are diagnosed with cancer, and tragically, 1 in 5 do not survive. Those who do survive often develop chronic conditions or severe illness due to treatment. Despite these alarming statistics, only 4% of federal funding goes towards pediatric cancer research. AB 703 establishes the Pediatric Cancer Research Voluntary Contribution Fund, which will allow Californians to donate towards pediatric cancer research, and positions our state as a leader in the fight against childhood cancer.
Arguments in Support
This bill is co-sponsored by the American Cancer Society Cancer Action Network, which notes the following:
Most childhood cancers are caused by DNA changes (mutations) that happen early in the child's life, sometimes even before birth. Because of this, there are not many known risk factors or ways to prevent childhood cancers. This makes research into childhood cancer that much more important. The more we can understand why DNA changes happen early in a child's life, the better the chances we will be able to prevent and develop new treatments for childhood cancer.
There has been far too little research on childhood cancer treatment. Two-thirds of childhood cancer survivors will have long-lasting chronic health conditions from treatment such as heart and other organ damage, infertility, stunted bone growth and increased risk of secondary cancers. Increased funding for more childhood cancer research could help develop treatments with less long-term side effects.
Arguments in Opposition
None on file
FISCAL COMMENTS
The FTB estimates that this bill would reduce General Fund revenues by $6,000 in both fiscal year (FY) 2026-27 and FY 2027-28.
VOTES
ASM REVENUE AND TAXATION: 6-0-1
YES: Gipson, Bains, DeMaio, Garcia, McKinnor, Quirk-Silva
ABS, ABST OR NV: Ta
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Sanchez, Arambula, Calderon, Caloza, Dixon, Elhawary, Fong, Mark González, Hart, Pacheco, Solache, Ta, Alanis
ABS, ABST OR NV: Pellerin
UPDATED
VERSION: April 21, 2025
CONSULTANT: M. David Ruff / REV. & TAX. / (916) 319-2098 FN: 0000314
Date of Hearing: April 30, 2025
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 703
Author:(Lee) – As Amended Ver:April 21, 2025
Policy Committee: | Revenue and Taxation | Vote: | 6 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill establishes the California Pediatric Cancer Research Voluntary Tax Contribution Fund (Fund) on the Personal Income Tax (PIT) return.
Specifically, this bill:
- Requires the Franchise Tax Board (FTB) to revise the PIT return form to designate a space for the Fund and allows, for taxable years beginning January 1, 2025, and before January 1, 2032, a taxpayer to donate a portion of their PIT refund to the Fund.
- Establishes the Fund in the State Treasury, requires FTB to notify the State Controller (SCO) of the amount of refund money designated by taxpayers for the Fund, and requires the SCO to transfer this designated amount from the PIT Fund to the Fund.
- Provides a continuous appropriation from the Fund, as follows:
- To FTB and the SCO for reimbursement of related administrative costs.
- To the Regents of the University of California (UC) for distribution of grants to research the causes and treatments for, and expand community-based education on, pediatric cancer. The UC may use up to 5% of the appropriation to administer and promote the grant program.
- Requests the UC report certain grant program expenditures on the UC website.
- Requires FTB to annually estimate whether the Fund will receive the minimum contribution amount to remain on the PIT return in the next taxable year.
FISCAL EFFECT:
- Beginning fiscal year 2026-27, annual General Fund (GF) revenue loss of approximately $6,000. FTB generally assumes $6,000 in GF revenue loss for every $250,000 in Fund contributions.
- Minor and absorbable costs to FTB and the SCO to administer another voluntary contribution fund (VCF) program.
- Minor and absorbable costs to the UC to administer the grant program and report specified information.
COMMENTS:
- Purpose. According to the author, “Each year, approximately 15,000 children are diagnosed with cancer, and tragically, 1 in 5 do not survive…Despite these alarming statistics, only 4% of federal funding goes towards pediatric cancer research.” The author asserts this bill “will allow Californians to donate towards pediatric cancer research, and positions our state as a leader in the fight against childhood cancer.” This bill is co-sponsored by the American Cancer Society Cancer Action Network and supported by other cancer research groups and the UC.
- Background.
VCFs. Existing law allows a taxpayer to donate an amount in excess of their PIT liability to one or more VCFs listed on the PIT return. There were 18 VCFs listed on the 2024 return. Generally, a VCF remains on the PIT return until a statutory sunset date, but if FTB determines the VCF fails to meet a $250,000 minimum contribution amount, the VCF is statutorily repealed and FTB removes the VCF from the return.
VCFs Administered by the UC. The UC currently administers two VCFs on the PIT return related to cancer research. Proceeds raised from the California Breast Cancer Research Voluntary Tax Contribution Fund (Breast Cancer Fund) are allocated to UC to support the Breast Cancer Research Program. Proceeds raised from the California Cancer Research Voluntary Tax Contribution Fund (Cancer Fund) are allocated to UC for distribution of grants to (a) conduct research on the causes and treatments for cancer, (b) expand community-based education on cancer, and (c) provide culturally sensitive and appropriate prevention and awareness activities targeted toward communities that are disproportionately at risk or afflicted by cancer. The Breast Cancer Fund and Cancer Fund have raised $364,902 and $362,544, respectively, in 2024, and are set to sunset after the 2031 return. This bill creates a third cancer-related VCF administered by the UC to distribute grants supporting pediatric cancer research and education.
- Related Legislation. AB 241 (Tangipa) adds the Wildfire and Vegetation Management Voluntary Tax Contribution Fund on the PIT return. AB 241 is pending hearing by the Assembly Revenue and Taxation Committee.
AB 829 (Sharp-Collins) adds the Parkinson’s Disease Research Voluntary Tax Contribution Fund on the PIT return. AB 829 is pending hearing by the Assembly Revenue and Taxation Committee.
Analysis Prepared by: Irene Ho / APPR. / (916) 319-2081
Date of Hearing: April 7, 2025
ASSEMBLY COMMITTEE ON REVENUE AND TAXATION
Mike Gipson, Chair
ABPCA Bill Id:AB 703 (
Author:Lee) – As Amended Ver:March 24, 2025
Majority vote. Fiscal committee.
SUBJECT: California Pediatric Cancer Research Voluntary Tax Contribution Fund
SUMMARY: Authorizes the addition of the California Pediatric Cancer Research Voluntary Tax Contribution Fund (Fund) as a voluntary contribution fund (VCF) on the personal income tax (PIT) return. Specifically, this bill:
- Contains the following legislative findings and declarations:
- Childhood cancer is the leading cause of disease-related death in children in the United States. Unlike many adult cancers, pediatric cancers are biologically distinct and require specialized research to develop effective treatments. Despite this, only 8% of federal cancer research funding is dedicated to childhood cancers, leaving a significant gap in resources needed for advancements in care;
- Many pediatric cancers, such as diffuse intrinsic pontine glioma (DIPG) and other rare brain tumors, have survival rates near 0%, with no significant treatment advancements in decades. For other childhood cancers, while the five-year survival rate is 83.3%, many survivors face lifelong health complications, including organ damage, secondary cancers, and cognitive impairments due to the toxic nature of current treatments. Unlike adult cancers, most pediatric cancers are not preventable, making research into safer and more effective therapies essential;
- The impact of childhood cancer extends beyond the patient, placing immense physical, emotional, and financial strain on families. Many parents leave jobs or relocate to access treatment, leading to financial hardship. In California, racial and ethnic disparities persist in pediatric cancer incidence and outcomes. Hispanic children have higher overall cancer rates than Black children (16.0 vs. 13.1 per 100,000), while White children experience the highest rates of brain and central nervous system tumors. These disparities highlight the urgent need for equitable access to research, treatment, and support services across all communities; and,
- It is the intent of the Legislature, in enacting this bill, to establish a coordinated statewide funding mechanism to advance research, treatment, and support systems for pediatric cancer. This will support research by scientists and clinicians at California cancer research centers, hospitals, and universities to develop innovative therapies and improve access to clinical trials. By enacting the Fund, California can lead the way in pediatric cancer research, ultimately improving survival rates and quality of life for children diagnosed with this devastating disease.
- Establishes the Fund in the State Treasury.
- Provides that all money in the Fund shall be continuously appropriated and allocated to the:
- Franchise Tax Board (FTB) and the State Controller for reimbursement of all administrative costs incurred; and,
- Regents of the University of California:
- For distribution of grants to conduct research on the causes and treatments for pediatric cancer and to expand community-based education on pediatric cancer; and,
- For reimbursement of any costs incurred by the Regents for administering the grant program.
- Requests that the Regents report on the Regents' internet website the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, including, without limitation, information regarding recipients of funds.
- Provides that, except as otherwise specified, the Fund's statutory provisions shall remain in effect only until January 1, 2033, and shall be repealed on December 1 of that year.
- Requires the Fund to meet a standard minimum contribution amount of $250,000 to remain in effect.
EXISTING LAW:
- Allows taxpayers to contribute to one or more of 18 VCFs on the 2024 PIT return. (Revenue and Taxation Code (R&TC) Section 18730 et seq.)
- Requires each VCF to meet an annual minimum contribution amount to remain in effect, except for the California Firefighters' Memorial Voluntary Tax Contribution Fund, the California Peace Officer Memorial Foundation Voluntary Tax Contribution Fund, the California Senior Citizen Advocacy Voluntary Tax Contribution Fund, and the California Seniors Special Fund. (R&TC Sections 18801 et seq., 18805 et seq., 18730 et seq., and 18771 et seq.)
- Provides a specific sunset date for each VCF, except for the California Seniors Special Fund and the State Parks Protection Fund. (R&TC Sections 18771 et seq. and 18900.1 et seq.)
- Requires the statutory provisions establishing a VCF to remain in effect only until January 1 of the seventh calendar year following the VCF's first appearance on the PIT return. (R&TC Section 18873.)
- Allows taxpayers to contribute to the California Cancer Research Voluntary Tax Contribution Fund via a checkoff on the PIT return. Moneys in this VCF are continuously appropriated to the Regents for distribution of grants to:
- Conduct research on the causes and treatments for cancer;
- Expand community-based education on cancer; and,
- Provide culturally sensitive and appropriate prevention and awareness activities targeted toward communities that are disproportionately at risk or afflicted by cancer. (R&TC Section 18861 et seq.)
- Conduct research on the causes and treatments for cancer;
- Allows taxpayers to contribute to the California Breast Cancer Research Voluntary Tax Contribution Fund via a checkoff on the PIT return. Moneys in this VCF are continuously appropriated to the University of California to support the Breast Cancer Research Program. Additionally, the University of California is prohibited from using more than 5% of the money allocated to it for administering and promoting the program.
FISCAL EFFECT: The FTB estimates that this bill would reduce General Fund revenues by $6,000 in both fiscal year (FY) 2026-27 and FY 2027-28.
COMMENTS:
- The author has provided the following statement in support of this bill:
Cancer is the leading cause of death by disease for children in the United States. Each year, approximately 15,000 children are diagnosed with cancer, and tragically, 1 in 5 do not survive. Those who do survive often develop chronic conditions or severe illness due to treatment. Despite these alarming statistics, only 4% of federal funding goes towards pediatric cancer research. AB 703 establishes the Pediatric Cancer Research Voluntary Contribution Fund, which will allow Californians to donate towards pediatric cancer research, and positions our state as a leader in the fight against childhood cancer.
- This bill is co-sponsored by the American Cancer Society Cancer Action Network, which notes the following:
Most childhood cancers are caused by DNA changes (mutations) that happen early in the child's life, sometimes even before birth. Because of this, there are not many known risk factors or ways to prevent childhood cancers. This makes research into childhood cancer that much more important. The more we can understand why DNA changes happen early in a child's life, the better the chances we will be able to prevent and develop new treatments for childhood cancer.
There has been far too little research on childhood cancer treatment. Two-thirds of childhood cancer survivors will have long-lasting chronic health conditions from treatment such as heart and other organ damage, infertility, stunted bone growth and increased risk of secondary cancers. Increased funding for more childhood cancer research could help develop treatments with less long-term side effects.
- This bill is supported by the University of California, which notes the following:
UC is a leader in cancer care and research through our five National Cancer Institute-designated Comprehensive Cancer Centers and we treat pediatric cancer patients at our four children's hospitals. The American Cancer Society estimates that approximately 9,550 children will be diagnosed with cancer in 2025. This bill will create a new voluntary tax fund, and the UC Office of the President will distribute grants to conduct research on the causes and treatments for pediatric cancer and to expand education on pediatric cancer. The UC Cancer Research Coordinating Committee in the UC Office of the President currently administers two other grant programs from funds collected through voluntary tax contribution funds for cancer and breast cancer research. The UC is well positioned to administer this new pediatric cancer research voluntary tax contribution fund. Like our other programs, the funding collected through this new tax check-off will be distributed through a competitive grant application process.
- Committee Staff Comments:
- So many causes, so little space: There are countless worthy causes that would benefit from the inclusion of a VCF on the state's income tax returns. At the same time, space on the returns is limited. Thus, it could be argued that the current system for adding VCFs to the form is subjective and essentially rewards organizations and causes that can convince the Legislature to include their fund on the form.
- What would this bill do? This bill would establish the Fund as a means of providing a dedicated funding source for pediatric cancer research. Specifically, this bill calls for Fund moneys to be allocated to the Regents for the distribution of grants. These grants, in turn, would be for pediatric cancer research and for expanding community-based education on pediatric cancer.
- The other cancer VCFs: As noted above, there are currently two VCFs dedicated to cancer research on the PIT return. The first is the California Cancer Research Voluntary Tax Contribution Fund. The University of California Office of the President notes the following in connection with this VCF:
The CCRVTC fund is administered by the Cancer Research Coordinating Committee (CRCC), a University of California systemwide research program that supports cutting edge cancer research selected through competitive peer review. The CRCC is comprised of UC faculty from all 10 campuses across California who are experts in a variety of cancer research disciplines, and who provide independent merit review of proposals submitted in response to an annual Request for Proposals. Leveraging the highly rigorous review process and oversight of the CRCC, the program is able to administer the CCRVTC funds for less than five percent of the annual donations. Over 95 percent of the donations goes directly to supporting research.
According to the FTB, the California Cancer Research Voluntary Tax Contribution Fund received valid contributions of $437,025 in 2022; $427,091 in 2023; and $362,544 in 2024.
The second VCF related to cancer research is the California Breast Cancer Research Voluntary Tax Contribution Fund. As noted above, moneys in this fund are allocated to the University of California to support the Breast Cancer Research Program. The FTB notes that this VCF received valid contributions of $436,035 in 2022, $413,725 in 2023; and $364,902 in 2024.
- Leveling the field: In an effort to promote a fair playing field, the Legislature enacted a series of requirements for new and extended VCFs. Specifically, R&TC Section 18873 was added by SB 1476 (Committee on Governance and Finance), Chapter 597, Statutes of 2016, to bring a degree of uniformity and improvement to the disparate VCF statutes. Among other things, Section 18873 provides the following parameters:
- The words "voluntary tax contribution" shall be included as part of the name of the fund;
- The website of the fund's administering agency shall report the process for awarding money, the amount of money spent on administration, and an itemization of how program funds were awarded, as specified;
- The minimum contribution amount that must be received for the fund to continue appearing on the tax return is $250,000, without subsequent inflation adjustments; and,
- The statutory provisions establishing a VCF shall remain in effect only until January 1 of the seventh calendar year following the VCF's first appearance on the return.
- Amendments suggested to comply with Committee's VCF policy: According to this Committee's formally adopted policy on VCFs, "[a]ll new checkoffs will be subject to queuing rules intended to ensure that no new checkoff is added to the form until an existing checkoff is removed or space becomes available." As such, Committee staff recommends the following amendments to bring this bill into compliance with the Committee's policy on VCFs:
- On page 3, line 39, delete "The" and insert "When another voluntary contribution designation is removed from the tax return, or as soon as space is available, whichever occurs first, the"; and,
- On page 5, in lines 2 and 3, delete "January 1, 2033, and as of December 1 of that year is repealed." and insert "January 1 of the seventh calendar year following the first appearance of the California Pediatric Cancer Research Voluntary Tax Contribution Fund on the tax return, and is repealed as of December 1 of that year."
- Administrative costs: As noted above, there are currently two University of California administered VCFs on the PIT return related to cancer research. The first, which supports general cancer research, specifically authorizes the University of California to use VCF moneys for full reimbursement of all administrative costs. Nevertheless, the University of California notes that they currently use less than 5% of this VCF's moneys to reimburse administrative costs. The second VCF, which supports breast cancer research, statutorily prohibits the University of California from using more than 5% of VCF moneys for administration and promotion.
- Leveling the field: In an effort to promote a fair playing field, the Legislature enacted a series of requirements for new and extended VCFs. Specifically, R&TC Section 18873 was added by SB 1476 (Committee on Governance and Finance), Chapter 597, Statutes of 2016, to bring a degree of uniformity and improvement to the disparate VCF statutes. Among other things, Section 18873 provides the following parameters:
This bill, in turn, would authorize full reimbursement of all costs incurred by the University of California in administering this program. The Committee and author may wish to consider amendments formally capping administrative reimbursement at 5% consistent with best practices and the current efficiencies demonstrated by the University of California's stewardship of the California Cancer Research Voluntary Tax Contribution Fund.
- Current legislation:
- AB 241 (Tangipa) would authorize the addition of the Wildfire and Vegetation Management Voluntary Tax Contribution Fund as a VCF on the PIT return. AB 241 is currently pending hearing by this Committee.
- AB 829 (Sharp-Collins) would authorize the addition of the Parkinson's Disease Research Voluntary Tax Contribution Fund as a VCF on the PIT return. AB 829 is currently pending hearing by the Assembly Committee on Health.
- Prior legislation:
- AB 1983 (Maienschein), Chapter 234, Statutes of 2024, established the Prevention of Animal Homelessness and Cruelty Voluntary Tax Contribution Fund.
- AB 511 (Dixon), Chapter 265, Statutes of 2023, established the California ALS Research Network Voluntary Tax Contribution Fund.
- AB 3051 (Muratsuchi), of the 2023-24 Legislative Session, would have established the California K-12 Climate Change Education Voluntary Tax Contribution Fund. AB 3051 was held on the Suspense File of the Assembly Committee on Appropriations.
- Current legislation:
REGISTERED SUPPORT / OPPOSITION:
Support
American Cancer Society Cancer Action Network (Co-Sponsor)
California Life Sciences
University of California
Opposition
None on file
Analysis Prepared by: M. David Ruff / REV. & TAX. / (916) 319-2098
Discussed in Hearing
Assembly Floor
Assembly Standing Committee on Revenue and Taxation
Bill Author
Bill Co-Author(s):